Eloxx Pharmaceuticals (ELOX) Research & Development (2010 - 2026)
Eloxx Pharmaceuticals' Research & Development came in at $2.84 million for Q2 2026, up 216.3% from $898,000 a year earlier and up 71.2% from the prior quarter.
Powered by 
Analysis
Eloxx Pharmaceuticals (ELOX) Research & Development (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Eloxx Pharmaceuticals reported Research & Development of $5.91 million, up 41.3% year-over-year; for FY2025, it was $3.06 million, down 14.6% from FY2024.
- Research & Development has declined in each of the last three years, with a five-year compound annual growth rate of -26.8% (FY2020 to FY2025).
- Going back by year, Research & Development was $3.58 million in FY2024 (-58.4%), $8.6 million in FY2023 (-63.8%), $23.73 million in FY2022 (+3.6%) and $22.9 million in FY2021 (+56.9%).
- The Q2 2026 figure represents the highest quarterly Research & Development since Q1 2023.
- The fastest year-over-year change in Research & Development over five years came in Q1 2026 (growth of 225.3%), and the weakest in Q3 2023 (a decline of 74.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.78 Bn | 1,135.37 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 635.34 Bn | 553.86 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.48 Bn | 476.60 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 377.08 Bn | 331.46 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 304.13 Bn | 268.12 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.48 Bn | 241.16 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.75 Bn | 197.15 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.09 Bn | 168.29 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 172.59 Bn | 119.24 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Eloxx Pharmaceuticals | 88.26 Mn | 14.58 Mn | - | 2.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.84 Mn |
| Mar 31, 2026 | 1.66 Mn |
| Jun 30, 2025 | 898,000.00 |
| Mar 31, 2025 | 510,000.00 |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 2.34 Mn |
| Mar 31, 2023 | 3.49 Mn |
| Dec 31, 2022 | 3.30 Mn |
| Sep 30, 2022 | 4.88 Mn |
| Jun 30, 2022 | 7.65 Mn |
| Mar 31, 2022 | 7.90 Mn |
| Dec 31, 2021 | 7.91 Mn |
| Sep 30, 2021 | 5.21 Mn |
| Jun 30, 2021 | 5.70 Mn |
| Mar 31, 2021 | 4.07 Mn |
| Dec 31, 2020 | 2.64 Mn |
| Sep 30, 2020 | 3.45 Mn |
| Jun 30, 2020 | 3.74 Mn |
| Mar 31, 2020 | 4.77 Mn |
API Access
Eloxx Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ELOX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ELOX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ELOX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();